Global Hemostasis Valve Market Regional Analysis
North America is expected to account for largest market share in global hemostasis valve market, owing to factors such as increasing presence of key players and their involvement in the innovation associated with the hemostasis valve. For instance, in 2017, Qosina added four new Y-connecter hemostasis valve to its product line. Y-connector helps healthcare professional to handle hemostasis valve comfortably.
Growing prevalence of blood disorder disease is another factor that is expected to drive hemostasis valve market growth in North America. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2019, in the U.S., the number of patient suffering from the hemophilia was estimated around 20,000, based on the expected death and birth since 1994. Moreover, according to the same source, most of the patient suffering from hemophilia were diagnosed at young age only.
Europe is expected to exhibit highest CAGR over the forecast period due to increasing prevalence of hemophilia, which is a blood related genetic disorder. For instance, in 2018, according to WHO, in U.K., around 6,000 people suffered from hemophilia. In addition, according to the same source, in 2018, around 5,400 people suffered from hemophilia A while 1,100 people suffered from hemophilia B.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients